Phibro Animal Health (PAHC) Declares $0.10 Quarterly Dividend; 1.2% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Cantor Fitzgerald Raises Price Target on Phibro Animal Health (PAHC) Based on Growth Prospects
May 13, 2015 12:14 PM EDTCantor Fitzgerald reiterates its Buy rating on Phibro Animal Health Corp. (Nasdaq: PAHC), and raised the price target to $42.00 (from $36.00), based on growth prospects.
Notably, on Tuesday night, Phibro Animal management updated its FY15 guidance, which is now revenue of $749 - $754M in revenue (from $739 - $759M), adjusted EBITDA of $109 - $110M in adjusted EBITDA (from $103 -... More
Guggenheim Remains Positive on Phibro Animal Health (PAHC), Raises Price Target to $40
May 12, 2015 11:34 AM EDTGuggenheim maintains a Buy rating on Phibro Animal Health Corp. (NASDAQ: PAHC), and raised the price target to $40.00 (from $35.00), following F3Q15 beat. PAHC reported an adjusted diluted EPS of $0.41 ($0.05 higher than consensus and $0.07 better than Guggenheim estimate). PAHC management raised the '15 EPS guidance from... More
Phibro Animal Health (PAHC) Tops Q3 EPS by 5c; Guides FY15 EPS Above Expectations
May 11, 2015 4:51 PM EDTPhibro Animal Health (NASDAQ: PAHC) reported Q3 EPS of $0.41, $0.05 better than the analyst estimate of $0.36. Revenue for the quarter came in at $187 million versus the consensus estimate of $187.8 million.
Phibro Animal Health sees FY2015 EPS of $1.65-$1.67, versus the consensus of $1.62. Phibro Animal... More
